| 注册
首页|期刊导航|天津中医药|HPLC-MS/MS法同时测定大鼠血浆中山楂叶提取物3种黄酮类成分及其药代动力学研究

HPLC-MS/MS法同时测定大鼠血浆中山楂叶提取物3种黄酮类成分及其药代动力学研究

马浩玲 张德芹 丁丽琴 陈新则 吴晓磊 伍明江 邱峰

天津中医药2017,Vol.34Issue(4):266-271,6.
天津中医药2017,Vol.34Issue(4):266-271,6.DOI:10.11656/j.issn.1672-1519.2017.04.16

HPLC-MS/MS法同时测定大鼠血浆中山楂叶提取物3种黄酮类成分及其药代动力学研究

Simultaneous determination of three flavonoids in hawthorn leaves extract by HPLC-MS/MS method and analysis of their pharmacokinetics in plasma of rats

马浩玲 1张德芹 1丁丽琴 1陈新则 1吴晓磊 1伍明江 1邱峰1

作者信息

  • 1. 天津中医药大学中医药研究院,天津市现代中药重点实验室-省部共建国家重点实验室培育基地,天津 300193
  • 折叠

摘要

Abstract

[Objective] To establish a HPLC-MS/MS method for the stimultancous pharmacokinetic study of vitexin-4"-O-glucoside(VOG), vitexin-2"-O-rhamnoside(VOR) and vitexin(VIT) in rat plasma after administration of hawthorn leaves extract orally. [Methods] Samples of plasma were obtained at different time after rats were administrated with three doses of hawthorn leaves extract (1, 2, 4 g/kg). After the deproteinization by methanol, extract of plasma samples were separated on a Agilent ZORBAX XDB-C18 column (3.5μm,2.1×50 mm) with gradient elution using methanol and water (containing 0.1%formic acid) as mobile phase. Mass spectrometric detection was carried out by multiple reaction monitoring (MRM) using electrospray ionization in negative ion mode. [Results] A good linearity of VIT, VOG and VOR was shown in the ranges of 0.50~500.0 ng/mL (r=0.998), 1.0~1000.0 ng/mL(r=0.999) and 1.0~1000.0 ng/mL(r=0.998), respectively. The methods of precision, accuracy, recovery and stability are in line with the requirements of determination of biological samples. [Conclusion] The method is proved to be simple, rapid, and specific, and to be suitable for the simultaneous determination of VIT, VOG and VOR in plasma of rats and the pharmacokinetic study.

关键词

药代动力学/高效液相色谱质谱联用法/山楂叶提取物

Key words

pharmacokinetics/HPLC-MS/MS/hawthorn leaves extract

分类

医药卫生

引用本文复制引用

马浩玲,张德芹,丁丽琴,陈新则,吴晓磊,伍明江,邱峰..HPLC-MS/MS法同时测定大鼠血浆中山楂叶提取物3种黄酮类成分及其药代动力学研究[J].天津中医药,2017,34(4):266-271,6.

基金项目

国家自然科学基金重点项目(81430095) (81430095)

国家重大新药创制科技重大专项(2012ZX09101212). (2012ZX09101212)

天津中医药

OACSTPCD

1672-1519

访问量0
|
下载量0
段落导航相关论文